Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

The Immune Response Corporation and Bayer to codevelop hemophilia A gene therapy

July 19, 1996

No Comments

AlphaNine SD cleared by FDA

July 19, 1996

No Comments

C85: TxB2 production/phosphoinositide breakdown inhibitor

July 19, 1996

No Comments

Terumo discloses fibrinogen (gpIIb/IIIa) antagonists

July 19, 1996

No Comments

Platelet aggregation inhibitors from Meiji Seika

July 19, 1996

No Comments

Fibrinogen antagonists from DuPont Merck

July 19, 1996

No Comments

Fibrinogen antagonists from Merck & Co.

July 19, 1996

No Comments

BASF reveals thrombin inhibitor as thrombosis/arterial reocclusion therapy

July 19, 1996

No Comments

NovoSeven hits U.K. market

July 12, 1996

No Comments

TxA2 antagonists/TxA2 synthase inhibitors from Fujisawa

July 12, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

BioWorld Science, Hematologic
RSS

The Immune Response Corporation and Bayer to codevelop hemophilia A gene therapy

AlphaNine SD cleared by FDA

C85: TxB2 production/phosphoinositide breakdown inhibitor

Terumo discloses fibrinogen (gpIIb/IIIa) antagonists

Platelet aggregation inhibitors from Meiji Seika

Fibrinogen antagonists from DuPont Merck

Fibrinogen antagonists from Merck & Co.

BASF reveals thrombin inhibitor as thrombosis/arterial reocclusion therapy

NovoSeven hits U.K. market

TxA2 antagonists/TxA2 synthase inhibitors from Fujisawa

Today's news in brief

Today's news in brief

J&J’s Ottava robotic system approved for US pivotal trial

Less microglia activity may improve APOE4’s effect in Alzheimer’s

‘Evo’ AI can design complete genomes

BioWorld Science, Hematologic RSS

BioWorld Science, Hematologic
RSS